In research, GTx (United States) stands highest in Medicine (#5,056 of 8,541 worldwide), Health Sciences (#6,825 of 9,902 worldwide) and Surgery (#1,123 of 1,532 worldwide), 2022-now. Relative to its size it is most specialised in Cardiology and Cardiovascular Medicine (Cardiology and Cardiovascular Medicine is 4.2× its share of world research).
Each strip is that field's whole ranked pool, with the notch where GTx (United States) sits in it, in the colour
of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average
differs by field (from about 6% in Dentistry to 21% in Economics).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.
Life Sciences15%Physical Sciences10%Health Sciences58%Social Sciences16%
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Where its research is concentrated relative to its size: Cardiology and Cardiovascular Medicine takes 4.2× the share of its output that it takes of world research.
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
more than its size predictsabout as predictedless
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 2.8×. Every wedge is a field page.
All 26 fields, with their numbers
Medicine2.84×472 works
Immunology and Microbiology2.03×18 works
Neuroscience1.65×23 works
Nursing1.43×6 works
Economics, Econometrics and Finance1.40×26 works
Biochemistry, Genetics and Molecular Biology1.38×63 works
Dentistry1.20×5 works
Pharmacology, Toxicology and Pharmaceutics1.12×3 works
What are the most cited papers from GTx (United States)?
The most cited paper from GTx (United States) is "The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial" (James T. Dalton, K. Gary Barnette, Casey E. Bohl et al., 2011), with 402 citations. Next come "Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)" (177) and "Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs" (157).
Which keywords describe research at GTx (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Cardiovascular Disease, Teaching Methods, Educational Technologies, Digital Education, Student Competencies, Pedagogy and Inflammation.
▲ more of its work than of the world's◆ about the world's share▼ less than the world's
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
Epidemiology79▲ 2.3×113 topics
Inflammation48▲ 2.6×76 topics
Cardiovascular Disease41▲ 4.1×34 topics
Pedagogy30▲ 7.0×6 topics
Educational Technologies30▲ 38×2 topics
Teaching Methods30▲ 21×2 topics
Digital Education30▲ 23×1 topic
Student Competencies30▲ 53×1 topic
Globalization28▲ 1.63×21 topics
Treatment26▲ 2.5×43 topics
Risk Factors24▲ 2.6×31 topics
Entrepreneurship22▲ 6.5×5 topics
Diagnosis22▲ 2.7×38 topics
Economic Development22▲ 3.1×7 topics
Digital Economy21▲ 12×3 topics
Metabolic Syndrome20▲ 2.9×22 topics
Investment20▲ 20×2 topics
Industrial Enterprises20▲ 68×1 topic
Innovation Economics20▲ 68×1 topic
Chemotherapy19▲ 3.1×23 topics
Mortality19▲ 3.9×13 topics
Hypertension19▲ 7.6×14 topics
Immunotherapy19▲ 3.0×19 topics
Guidelines16▲ 4.0×13 topics
Global Burden16▲ 3.4×12 topics
Clinical Guidelines16▲ 6.1×9 topics
Global Governance15▲ 7.3×5 topics
Genetic Mutations14▲ 3.8×22 topics
Migration14▲ 4.8×8 topics
Myocardial Infarction14▲ 6.8×7 topics
Postcolonialism14▲ 11×6 topics
Crisis Management13▲ 30×2 topics
Social Exclusion13▲ 20×2 topics
Biopolitics13▲ 19×1 topic
Education Reform13▲ 61×1 topic
Cardiovascular Events12▲ 11×4 topics
Energy Consumption12▲ 5.9×5 topics
Irrigation11▲ 65×1 topic
Water Efficiency11▲ 65×1 topic
Antiretroviral Therapy10▲ 7.4×6 topics
Which research topics does GTx (United States) publish most on?
Against the world's own shares: the tick on each track. Both are shares of its output, so they
sit on one scale and can be read against each other as well as against the world.
26%74%
openly available26.4%not open73.6%
World: 40% of research is openly available.
71%29%
with international co-authors71.3%domestic only28.7%
World: 18% is written across borders.
How has GTx (United States)'s research output changed?
Output in 2022-2025 was 53% lower than in 2018-2021.
grewheldshrank
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is GTx (United States) as a percentage of every work published that year, 0.0041% in 2024.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about GTx (United States). Posts are plain text and can be reported.